Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CXCR7 inhibitors for the treatment of cancer

CXCR7 inhibitors for the treatment of cancer

US Patent 11464786 · Granted Oct 11, 2022

Estimated economic value: $109,575,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating solid tumors with CCR2 antagonists2024
Compositions and methods for treating inflammatory bowel disease using CCR9 inhi2024
Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or2023
Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD2022
Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or2021
Methods of treating solid tumors with CCR2 antagonists2021
Compositions and methods for treating inflammatory bowel disease using a combina2021
Compositions and methods for treating inflammatory bowel disease using a combina2021
Compositions and methods for treating inflammatory bowel disease using CCR9 inhi2020
Precharging apparatus and power converter2017
Diagnosis of neurodegenerative diseases2015
Methods and compositions relating to alzheimer's disease2014